5 Most Volatile Stocks Under $5 For Day Trading

4. Aptevo Therapeutics Inc. (NASDAQ:APVO)

Latest Beta Reading: 5.24

Number of Hedge Fund Investors In Q3 2023: 4

Aptevo Therapeutics Inc. (NASDAQ:APVO) is an American biotechnology company developing cancer treatments. The firm ended its third quarter with $19.1 million in cash which was enough to cover all its current expenses for the third quarter for three quarters.

During Q3 2023, four out of the 910 hedge funds part of Insider Monkey’s database had bought and owned Aptevo Therapeutics Inc. (NASDAQ:APVO)’s shares. Out of these, the firm’s biggest shareholder was Hal Mintz’s Sabby Capital as it owned a $440,276 stake.

Follow Aptevo Therapeutics Inc. (NASDAQ:APVO)